Atlas Trials

Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations

Clinical trial NCT02418468 · COMPLETED

Trial details

NCT number
NCT02418468
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2015-04-28
Primary completion
2016-04-19
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.